Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier

JUNE 26, 2019 Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier Positions Quanterix to capitalize on significant growth opportunities with Nf-L applications in Alzheimer’s Disease, Multiple Sclerosis, and other neurodegenerative conditions Provides expected 200 bps of annualized company gross margin improvement, before impact of purchase price accounting, and expected to... Read more